Gynecologic Oncology | Specialty

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Mutations Pass From Primary to Recurrent Endometrial Cancer

June 26th 2012

Most recurrent endometrial tumors have the same PI3K/Akt mutation profile as found in the primary tumor.

Breast Cancer and Early-Onset Menopause

June 14th 2012

Whether surgically or medically induced, early menopause forces women to deal with a host of emotional, physical, and practical issues.

Avastin Delays Disease Progression in Platinum-Resistant Ovarian Cancer

June 2nd 2012

Combining bevacizumab with standard chemotherapy reduced the risk of disease progression by 52% in patients with platinum-resistant ovarian cancer.

Dr. Davidson on Screening for Ovarian Cancer

May 23rd 2012

Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, on Screening for Ovarian Cancer

PARP Inhibitors Intriguing Despite Research Setbacks

April 26th 2012

Despite initial disappointing findings on overall survival, PARP inhibitors remains under active investigation for patients with ovarian cancer.

Improved Survival in Women With Invasive Epithelial Ovarian Cancer and Germline BRCA Gene Mutations

March 26th 2012

Researchers are reporting better survival rates in women with invasive EOC and germline mutations in the tumor suppressor genes BRCA1 and BRCA2 than in patients who are noncarriers.

Dr. Birrer on the Ovarian Cancer Avastin OS Benefit

March 2nd 2012

Dr. Michael Birrer from Massachusetts General Hospital Cancer Center on the Ovarian Cancer Avastin OS Benefit

Benefits of Bevacizumab in Ovarian Cancer Clarified

March 1st 2012

Bevacizumab has failed to demonstrate statistically significant improvements in OS for women with recurrent ovarian cancer in 2 recent clinical trials.

Conference Features Debates on Clinical Controversies

February 21st 2012

The 9th International Symposium on Ovarian Cancer and Other Gynecologic Malignancies conference will bring professionals in the field up to date on the latest research into ovarian, uterine, cervical, and endometrial cancers.

Dr. Birrer Discusses the GOG0218 and ICON7 Trials

February 2nd 2012

Dr. Michael Birrer, from Massachusetts General Hospital Cancer Center, Discusses the GOG0218 and ICON7 Trials

BRCA1 and BRCA2 Mutations Yield Better Prognosis in Ovarian Cancer Patients

January 25th 2012

Patients with ovarian cancer who express BRCA1/2 mutations demonstrated a better overall survival after 5 years.

Brain Metastasis Common in Ovarian Cancer

January 20th 2012

Half of all women with advanced ovarian cancer who develop brain cancer have a single metastasis to the brain.

Fertility Treatment Increases Risk of Ovarian Cancer

January 16th 2012

Subfertile women who undergo ovarian stimulation for in vitro fertilization have an increased risk of ovarian malignancies.

Planned Cooperative Group Merger Is Generating Concern

January 5th 2012

A proposed overhaul of the NCI's clinical trials system has created anxiety among gynecologic researchers who fear projects in women's cancer will be diminished in a scramble for funding with more common malignancies.

November 2011: Trials in Progress

December 6th 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Oncology Meeting.

HPV Vaccination Completion Rates Increase, but Gaps Remain

December 2nd 2011

New findings demonstrate a recent increase in the annual completion rates of vaccination against human papillomavirus (HPV) infection.

Dr. Woodruff on Oncofertility Insurance Coverage

November 2nd 2011

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

Dr. Mills Gives Examples of Unexpected Drug Responses

October 28th 2011

Dr. Gordon Mills from MD Anderson Cancer Center Gives Examples of Unexpected Therapy Responses

October 2011: Trials in Progress

October 21st 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Meeting.

5 Abstracts Among SGO Highlights

September 30th 2011

This report highlights 5 abstracts relevant to the current and future management of patients with female pelvic malignancies.